Investing.com - Intracellular Th reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Intracellular Th announced earnings per share of $-0.57 on revenue of $71.9M. Analysts polled by Investing.com anticipated EPS of $-0.81 on revenue of $65.88M.
Intracellular Th shares are down 26.01% from the beginning of the year and are trading at $50.81 , down-from-52-week-high.
Intracellular Th shares gained 10.88% in intra-day trade after the report.
Intracellular Th follows other major Healthcare sector earnings this month
Intracellular Th's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar